Backed by more than a dozen investors, the biotech startup will use the funding to further a Phase 1 trial of its lead program CBX-250.
Proactive coordination is essential to protect patients, sponsors and trial integrity, especially as teams navigate the new UK Clinical Trial Regulation. Hear why alignment matters more...
Bull sharks may have a reputation as lone hunters, but new research reveals they actually form social bonds and even have preferred “friends.” After six years...
Nature Biotechnology, Published online: 18 March 2026; doi:10.1038/s41587-026-03055-x An engineered Escherichia coli Nissle 1917 strain carrying a synthetic arginine–nitric oxide (NO) circuit enables sustained intratumoral NO...
Nature Biotechnology, Published online: 18 March 2026; doi:10.1038/s41587-026-03054-y Solid tumors are sensitized to anti‑PD‑L1 immunotherapy by engineered E. coli to produce nitric oxide.
Nature Biotechnology, Published online: 18 March 2026; doi:10.1038/s41587-026-03061-z Peptides are sequenced by converting each amino acid into amplifiable DNA barcodes.
Post Content
Post Content
Post Content
Post Content